Gregory J. Flesher
2017 - Tokai Pharmaceuticals
In 2017, Gregory J. Flesher earned a total compensation of $966.6K as Chief Executive Officer at Tokai Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $575,111 |
| Salary | $290,000 |
| Other | $1,483 |
| Total | $966,594 |
Flesher received $575.1K in option awards, accounting for 59% of the total pay in 2017.
Flesher also received $100K in bonus, $290K in salary and $1.5K in other compensation.
Rankings
In 2017, Gregory J. Flesher's compensation ranked 9,139th out of 14,666 executives tracked by ExecPay. In other words, Flesher earned more than 37.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,139 out of 14,666 | 38th |
Division Manufacturing | 3,508 out of 5,770 | 39th |
Major group Chemicals And Allied Products | 1,201 out of 2,074 | 42nd |
Industry group Drugs | 962 out of 1,730 | 44th |
Industry Pharmaceutical Preparations | 754 out of 1,329 | 43rd |
Source: SEC filing on April 30, 2018.
Flesher's colleagues
We found five more compensation records of executives who worked with Gregory J. Flesher at Tokai Pharmaceuticals in 2017.
2017
Jodie Morrison
Tokai Pharmaceuticals
Chief Executive Officer
2017
John McBride
Tokai Pharmaceuticals
Chief Financial Officer
2017
Catherine Turkel
Tokai Pharmaceuticals
President
2017
Christine Ocampo
Tokai Pharmaceuticals
Chief Financial Officer
2017
Jon Kuwahara
Tokai Pharmaceuticals
Senior Vice President of Finance and Administration
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019